We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

185 hedge funds and large institutions have $860M invested in SANGAMO THERAPEUTICS INC in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 76 increasing their positions, 39 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 39

67% more call options, than puts

Call options by funds: $26.2M | Put options by funds: $15.7M

36% more capital invested

Capital invested by funds: $630M → $860M (+$230M)

4.74% more ownership

Funds ownership: 64.51% → 69.25% (+4.7%)

6% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 31

1% less funds holding

Funds holding: 187 → 185 (-2)

Holders
185
Holders Change
-2
Holders Change %
-1.07%
% of All Funds
4.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
76
Reduced
39
Closed
31
Calls
$26.2M
Puts
$15.7M
Net Calls
+$10.5M
Net Calls Change
+$2.07M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$71.5M
2
BG
Bellevue Group
Switzerland
+$38.8M
3
Citadel Advisors
Citadel Advisors
Florida
+$17.6M
4
BlackRock
BlackRock
New York
+$11.7M
5
N
Nuveen
North Carolina
+$8.41M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$9.23M
2
State Street
State Street
Massachusetts
-$5.37M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.96M
4
Bank of America
Bank of America
North Carolina
-$2.07M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$1.62M +$193K +18,138 +14%
IBT
52
International Biotechnology Trust
United Kingdom
$1.62M +$1.08M +102,000 +213%
DekaBank Deutsche Girozentrale
53
DekaBank Deutsche Girozentrale
Germany
$1.61M +$1.02M +95,700 +169%
State of Wisconsin Investment Board
54
State of Wisconsin Investment Board
Wisconsin
$1.59M -$535K -50,300 -25%
Citigroup
55
Citigroup
New York
$1.53M +$530K +49,864 +54%
TAM
56
Tocqueville Asset Management
New York
$1.53M +$6.38K +600 +0.4%
QI
57
QS Investors
New York
$1.37M -$38K -3,574 -3%
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
$1.33M +$187K +17,600 +17%
Ohio Public Employees Retirement System (OPERS)
59
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.31M +$20.1K +1,888 +2%
TCM
60
Tekla Capital Management
Massachusetts
$1.3M -$1.28M -120,770 -50%
Schroder Investment Management Group
61
Schroder Investment Management Group
United Kingdom
$1.25M – – –
WM
62
WS Management
Florida
$1.25M -$145K -13,633 -11%
SAMH
63
Shanda Asset Management Holdings
British Virgin Islands
$1.23M – – –
MSL
64
Mackay Shields LLC
New York
$1.22M +$774K +72,733 +179%
California Public Employees Retirement System
65
California Public Employees Retirement System
California
$1.2M -$184K -17,330 -13%
Man Group
66
Man Group
United Kingdom
$1.17M +$63.8K +6,000 +6%
T. Rowe Price Associates
67
T. Rowe Price Associates
Maryland
$1.14M +$5.31K +499 +0.5%
Wolverine Trading
68
Wolverine Trading
Illinois
$1.08M -$185K -17,429 -15%
Russell Investments Group
69
Russell Investments Group
United Kingdom
$1.07M – – –
UBS Group
70
UBS Group
Switzerland
$1.06M +$841K +79,056 +400%
JP Morgan Chase
71
JP Morgan Chase
New York
$1.05M +$25.2K +2,372 +2%
GIM
72
Granahan Investment Management
Massachusetts
$1.01M -$28.2K -2,652 -3%
PPA
73
Parametric Portfolio Associates
Washington
$987K +$73K +6,867 +8%
UCFA
74
United Capital Financial Advisors
Texas
$797K +$433K +40,730 +122%
AIG
75
American International Group
New York
$787K +$89K +8,370 +13%
1 2
3
4 5

SGMO Hedge Fund Activity: Q2 2019 in Review

185 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2019, worth a combined $860M — up 36% from $630M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new SGMO positions and 31 closed out — a net gain of 2 holders — while 76 added to existing stakes and 39 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $71.5M. The largest seller was Invesco, cutting an estimated $9.23M.

  • 185 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2019, down from 187 in Q1 2019.
  • Funds reported $860M of SANGAMO THERAPEUTICS INC stock for Q2 2019, up 36% quarter-over-quarter.
  • 33 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2019 and 31 closed out, a net change of +2 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2019 was Wellington Management Group, an estimated $71.5M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2019 was Invesco, an estimated $9.23M sold.

Based on aggregated 13F filings for Q2 2019.